These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2942992)

  • 1. Experiments on the toxicity of locoregional liver chemotherapy with 5-fluoro-2'-deoxyuridine and 5-fluorouracil in an animal model.
    Berger MR; Henne TH; Aguiar JL; Bartkowski R; Dörsam J; Geelhaar GH; Schlag P; Herfarth C; Schmähl D
    Recent Results Cancer Res; 1986; 100():148-56. PubMed ID: 2942992
    [No Abstract]   [Full Text] [Related]  

  • 2. Experiments on the efficacy and toxicity of locoregional chemotherapy of liver tumors with 5-fluoro-2'-deoxyuridine (FUDR) and 5-fluorouracil (5-FU) in an animal model.
    Bartkowski R; Berger MR; Aguiar JL; Henne TH; Dörsam J; Geelhaar GH; Schlag P; Herfarth C
    J Cancer Res Clin Oncol; 1986; 111(1):42-6. PubMed ID: 2936747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A clinical-pharmacological evaluation of hepatic arterial infusions of 5-fluoro-2'-deoxyuridine and 5-fluorouracil.
    Ensminger WD; Rosowsky A; Raso V; Levin DC; Glode M; Come S; Steele G; Frei E
    Cancer Res; 1978 Nov; 38(11 Pt 1):3784-92. PubMed ID: 151583
    [No Abstract]   [Full Text] [Related]  

  • 4. Continuous or bolus chemotherapy with 5-fluoro-2'-deoxyuridine in transplanted experimental liver tumors?
    Riemenschneider T; Ruf C; Späth G; Stuhldreier G; Elmouaouy A
    J Cancer Res Clin Oncol; 1988; 114(5):482-6. PubMed ID: 2972727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arterial, portal or combined arterio-portal regional chemotherapy in experimental liver tumours?
    Riemenschneider T; Ruf C; Kratzsch HC; Ziegler M; Späth G
    J Cancer Res Clin Oncol; 1992; 118(8):597-600. PubMed ID: 1387647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic infusion of 5-fluoro-2'-deoxyuridine (5-FUDR) into the hepatic artery of the dog.
    Khazei AM; Patel DD; Morgenthaler FR; MacDonald AJ; Sanadizadeh SM; Watkins E
    J Surg Res; 1970 Aug; 10(8):343-52. PubMed ID: 4193563
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatic artery versus portal vein and systemic infusion of fluorodeoxyuridine of rabbit VX-2 hepatic implants.
    Butler JA; Trezona TP; Nordestgaard A; State D
    Am J Surg; 1989 Jan; 157(1):126-9. PubMed ID: 2521278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic arterial infusion chemotherapy for cancer of the liver.
    Bland KI; Knutson CO; Max MH
    J Surg Oncol; 1980; 13(3):253-8. PubMed ID: 6445466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Locoregional administration of 5-fluoro-2'-deoxyuridine (FdUrd) in Novikoff hepatoma in the rat: effects of dose and infusion time on tumor growth and on FdUrd metabolite levels in tumor tissue as determined by 19F-NMR spectroscopy.
    Naser-Hijazi B; Berger MR; Schmähl D; Schlag P; Hull WE
    J Cancer Res Clin Oncol; 1991; 117(4):295-304. PubMed ID: 1829730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional chemotherapy for colorectal liver metastases: thirty years without patient benefit.
    Begos DG; Ballantyne GH
    J Surg Oncol; 1994 Jul; 56(3):139-44. PubMed ID: 8028342
    [No Abstract]   [Full Text] [Related]  

  • 11. The effects on liver metastases of circadian patterned continuous hepatic artery infusion of FUDR.
    Kemeny MM; Alava G; Oliver JM
    HPB Surg; 1994; 7(3):219-24. PubMed ID: 8155588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic arterial chemotherapy for colorectal cancer metastatic to the liver.
    van Riel JM; van Groeningen CJ; Giaccone G; Pinedo HM
    Oncology; 2000 Aug; 59(2):89-97. PubMed ID: 10971164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Animal experiment studies of the toxicity of fluorodeoxyuridine (FUDR) and 5-fluorouracil (FU) within the scope of regional liver infusion chemotherapy].
    Schlag P; Yi J; Friedl P; Hull W; Berger M
    Langenbecks Arch Chir; 1990; 375(2):81-6. PubMed ID: 2139486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intra-arterial and intravenous chemotherapy in the treatment of hepatic metastases of colorectal origin: review of the literature and preliminary results].
    Mazy V; Focan C; Dallemagne B; Focan-Henrard D; Longrée L; Markiewicz S; Weerts J; Jehaes C; Jacquet N; Demoulin JC
    Rev Med Liege; 1990 Mar; 45(3):105-16. PubMed ID: 2138809
    [No Abstract]   [Full Text] [Related]  

  • 15. [Locoregional chemotherapy of hepatic metastases of colorectal cancer].
    Rougier P; Lasser P; Droz JP; Elias D; Ghosn M; Ducreux M; Lumbroso J; Sidibe S
    Ann Gastroenterol Hepatol (Paris); 1987 Nov; 23(6):315-9. PubMed ID: 2962534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is hepatic infusion of chemotherapy effective treatment for liver metastases? Yes!
    Kemeny NE
    Important Adv Oncol; 1992; ():207-27. PubMed ID: 1533847
    [No Abstract]   [Full Text] [Related]  

  • 17. Systemic and arterial infusion chemotherapy for metastatic liver cancer.
    Sullivan RD
    Int J Radiat Oncol Biol Phys; 1976; 1(9-10):973-6. PubMed ID: 135748
    [No Abstract]   [Full Text] [Related]  

  • 18. The effects on toxicity of circadian patterning of continuous hepatic artery infusion.
    Kemeny MM; Alava G; Oliver JM; Smith FB
    HPB Surg; 1992 Apr; 5(3):185-93; discussion 193-4. PubMed ID: 1387318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatobiliary toxicity of 5-fluoro-2'-deoxyuridine. Intra-arterial versus portal venous routes of infusion.
    Andrews JC; Kuntsen C; Terio P; Priescorn D; Ensminger WD
    Invest Radiol; 1991 May; 26(5):461-4. PubMed ID: 1829068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implantable vascular access devices in the treatment of colorectal liver metastases.
    Clark CG
    Br J Surg; 1986 Jun; 73(6):419-21. PubMed ID: 2941108
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.